Retransplantation in Alport post-transplant anti-GBM disease

Kidney International

Volumn 65, Issue 2, 2004, Pages 675-681

  Browne, Gemma ^b   Brown, Paul A J ^b   Tomson, Charles R V ^b   Fleming, Stewart ^b   Allen, Andrew ^b   Herriot, Richard ^b   Pusey, Charles D ^b   Rees, Andrew J ^b   Turner, A Neil ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

Alport syndrome; Autoimmunity; Crescentic nephritis; Good pasture; Transplantation

Indexed keywords

ALEMTUZUMAB; ALLOANTIBODY; COLLAGEN TYPE 4; COLLAGENASE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE; T LYMPHOCYTE ANTIBODY;

ADULT; ALPORT SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPLEMENT FIXATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INSERTION; GLOMERULUS BASEMENT MEMBRANE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INSECT CELL; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY NECROSIS; KIDNEY TRANSPLANTATION; MEDICAL EXAMINATION; MEMBRANOUS GLOMERULONEPHRITIS; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; PERCEPTION DEAFNESS; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; REOPERATION; STOP CODON; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 1642520777     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00428.x     Document Type: Article

References (26)

1. KASHTAN CE, MICHAEL AF: Alport syndrome. Kidney Int 50:1445-1463, 1996
2. BYRNE MC, BUDISAVLJEVIC MN, FAN Z, et al: Renal transplant in patients with Alport's syndrome. Am J Kidney Dis 39:769-775, 2002.
3. DING J, ZHOU J, TRYGGVASON K, KASHTAN CE: COL4A5 deletions in three patients with Alport Syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5:161-168, 1994
4. BRAINWOOD D, KASHTAN C, GUBLER MC, TURNER AN: Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53:762-766, 1998
5. BLAKE MS, JOHNSTON KH, RUSSELL-JONES GJ, GOTSCHLICH RC: A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem 136:175-179, 1984
6. KASHTAN C, FISH AJ, KLEPPEL M, et al: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78:1035-1044, 1986
7. CALNE R, MOFFATT SD, FRIEND PJ, et al: Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 68:1613-1616, 1999
8. OLIVER TB, GOULDESBROUGH DR, SWAINSON CP: Acute crescentic glomerulonephritis associated with antiglomerular basement membrane antibody in Alport's syndrome after second transplantation. Nephrol Dial Transplant 6:893-895, 1991
9. KATBAMNA I, TURNER N, ROSS CN, PUSEY CD: Development and application of an ELISA for Goodpasture's disease based on sheep α3(IV)NC1 domains. J Clin Lab Immunol 47:11-24, 1995
10. RASSOUL Z, AL-KHADER AA, AL-SULAIMAN M, et al: Recurrent allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport's syndrome. Am J Nephrol 10:73-76, 1990
11. MILLINER DS, PIERIDES AM, HOLLEY KE: Renal transplantation in Alport's syndrome: anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57:35-43, 1982
12. GOLDMAN M, DEPIERREUX M, DE PAUW L, et al: Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport's syndrome: Case report and review of the literature. Transplant Int 3:82-85, 1990
13. SHAH B, FIRST MR, MENDOZA NC, et al: Alport's syndrome: Risk of glomerulonephritis induced by anti-glomerular-basement-membrane antibody after renal transplantation. Nephron 50:34-38, 1988
14. KASHTAN CE, BUTKOWSKI RJ, KLEPPEL MM, et al: Post-transplant anti-glomerular basement membrane nephritis in related males with Alport syndrome. J Lab Clin Med 116:508-515, 1990
15. HUDSON BG, KALLURI R, GUNWAR S, et al: The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3(IV) chain: Evidence from anti-GBM nephritis after renal transplantation. Kidney Int 42:179-187, 1992
16. VANGELISTA A, FRASCA GM, MARTELLA D, BONOMINI V: Glomerulonephritis in renal transplantation. Nephrol Dial Transplant 1(Suppl):42-46, 1990
17. DIAZ JI, VALENZUELA R, GEPHARDT G, et al: Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome. Arch Path Lab Med 118:728-731, 1994
18. KASHTAN CE, ATKIN CL, GREGORY MC, MICHAEL AF: Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kidney Int 36:669-674, 1989
19. SOLER PUJOL G, IOTTI R, DAVALOS MICHEL M, et al: Anti glomerular basement membrane disease in a renal transplant patient with Alport syndrome. Medicina 59:466-468, 1999
20. QUERIN S, NOEL LH, GRUNFELD JP, et al: Linear glomerular IgG fixation in renal allografts: Incidence and significance in Alport's syndrome. Clin Nephrol 25:134-140, 1986
21. TIPPING PG, KITCHING AR, CUNNINGHAM MA, HOLDSWORTH SR: Immunopathogenesis of crescentic glomerulonephritis. Current Opinion in Nephrology and Hypertension 8:281-286, 1999
22. PETEN E, PIRSON Y, COSYNS JP, et al: Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 52:823-826, 1991
23. GOBEL J, OLBRICHT CJ, OFFNER G, et al: Kidney transplantation in Alport's syndrome: Long-term outcome and allograft anti-GBM nephritis. Clinical Nephrology 38:299-304, 1992
24. KALLURI R, TORRE A, SHIELD CFR, et al: Identification of α3, α4, and α5 chains of type IV collagen as alloantigens for Alport post-transplant anti-glomerular basement membrane antibodies. Transplantation 69:679-683, 2000
25. PRICE RG, SPIRO RD: Studies on the metabolism of the renal glomerular basement membrane. J Biol Chem 252:8597-8602, 1977
26. JAIS JP, KNEBELMANN B, GIATRAS I, et al: X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J Am Soc Nephrol 11: 649-657, 2000